8-KThe WireRoutine
Company Update
Filed Aug 9, 2021 · 4y ago · Accession 0001564590-21-042647
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Oruka Therapeutics, Inc.
- Ticker
- ORKA
- CIK
- 907654
- Form type
- 8-K
- Filing date
- Aug 9, 2021
- Report date
- Aug 9, 2021
- Document
- abio-8k_20210809.htm
- Size
- 451 KB